Results-Financial Results for the quarter and year ended March 31, 2026
INDOBORAX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indo Borax & Chemicals reported standalone revenue of ₹21,545.11 Lakhs for FY 2025-26, up 22.94% from ₹17,526.11 Lakhs in the prior year, crossing the 20% revenue growth threshold. Standalone PAT grew to ₹4,973.97 Lakhs from ₹4,188.20 Lakhs (+18.8%), while consolidated PAT was ₹5,026.98 Lakhs. EBITDA margin compressed from ~30.4% to ~24.2% year-on-year. An exceptional item of ₹1,014.75 Lakhs was recorded (standalone), and the Board recommended a final dividend of ₹10 per share plus a special dividend of ₹30 per share (3,000% yield). The auditors issued an unmodified opinion with an Emphasis of Matter regarding an Inter Corporate Deposit of ₹5.09 Crores given to a party that has filed for corporate insolvency under the IBC code, 2016. The company continues to not provide interest on the disputed loan pending NCLT outcome. Cash flow from operations was strongly positive at ₹7,572.74 Lakhs (standalone).
Strong revenue growth of ~23% is positive, but margin compression and the unresolved ₹5.09 Crore ICD exposure (party under IBC) are cautionary flags for investors despite clean audit opinion.